News
June 22, 2022
TScan Therapeutics to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium
June 2, 2022
TScan Therapeutics to Participate in the 2022 Jefferies Healthcare Conference
May 31, 2022
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-101 for the Treatment of Hematologic Malignancies
May 19, 2022
TScan Therapeutics Presents Preclinical Data at the American Society of Gene and Cell Therapy 25th Annual Meeting
May 17, 2022
TScan Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
May 12, 2022
TScan Therapeutics to Host Virtual KOL Event to Discuss its Solid Tumor Program Strategy and Highlights from the ASGCT 25th Annual Meeting
May 9, 2022
TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones
May 2, 2022
TScan Therapeutics Announces Upcoming Presentations at the 25th American Society of Gene and Cell Therapy Annual Meeting
April 11, 2022
TScan Therapeutics Appoints Leiden Dworak, CPA, MBA, as Vice President, Finance
March 9, 2022